← All organizations

Fundación de investigación HM

Academic/HospitalWebsite ↗

Also known as: Fundación de investigación HM

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Dec 31, 2024

Timeline

2000s

Jul 1, 2003
Fundación de investigación HM— Founded

Drugs by trial phase (16 distinct, 10 trials)

Phase 3 (1 own, 0 via acquisition)

hydroxychloroquine

Phase 2 (14 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

olive

Indications

Studied for

Recent trials (11)

NCT06623162Lead sponsorPhase 2Dec 31, 2024
NCT06607692Lead sponsorPhase 2Oct 31, 2024
NCT04525638Lead sponsorPhase 2Jun 29, 2020
NCT04420299Lead sponsorPhase 2Jun 4, 2020
NCT04410562CollaboratorPhase 3May 13, 2020
NCT04348695Lead sponsorPhase 2Apr 12, 2020
NCT04009876Lead sponsorPhase 2May 1, 2019
NCT04010552Lead sponsorPhase 2May 1, 2019
NCT03053843Lead sponsorN/AMar 6, 2017
NCT03053843Reponsible party - principal investigatorN/AMar 6, 2017
NCT02928432CollaboratorPhase 2Jun 1, 2013

Details

Founded: Barcelona, ES Jul 1, 2003
Last known activity: Dec 31, 2024